logo

After The Bell

Share SHARE

Ollie's Bargain Outlet Holdings (OLLI) reported fourth quarter EPS of $0.39 after the bell Tuesday, compared to $0.26 a year ago. The consensus estimate was for EPS of $0.35. The stock is now up 0.70 on 118K shares. Ollie's traded in a narrow range throughout Tuesday's session and closed down by 0.15...

RH (RH) reported fourth quarter adjusted EPS of $0.68 after the close Tuesday, down from $0.98 a year ago. Analysts expected EPS of $0.05. The stock is now up 6.61 on 602K shares. RH climbed during the second half of the morning Tuesday and took out the session highs in late trade. The stock ended...

Depomed Inc. (DEPO) announced after the bell Tuesday that it James Schoeneck has resigned and that Arthur J. Higgins will replace him as President and Chief Executive Officer and member of the Board of Directors. The stock is now down 0.78 on 143K shares. Depomed declined during the first hour of...

Dave & Buster's Entertainment (PLAY) reported fourth quarter EPS of $0.63 after the close Tuesday, compared to $0.53 in the prior year period. Street expectations were for EPS of $0.59. The stock is now down 2.19 on 335K shares. Dave & Buster's Entertainment gapped up slightly Tuesday and advanced...

Verint Systems Inc. (VRNT) reported fourth quarter non-GAAP EPS of $0.90 after the bell Tuesday, which was flat with the prior year result. The consensus estimate was for EPS of $0.86. The stock is now up 3.25 on 22K shares. Verint Systems declined until mid-morning Tuesday, before settling into a...

Darden Restaurants Inc. (DRI) reported third quarter EPS of $1.32 after the bell Monday, up from $1.21 in the previous year. The consensus estimate was for EPS of $1.28. The stock is now up 2.67 on 135K shares. Darden Restaurants gapped open lower Monday and fell during the first half of the morning....

Red Hat Inc. (RHT) reported fourth quarter EPS of $0.61 after the close Monday, up from $0.52 last year. The result was in line with analysts' expectations. The company expects to report first quarter EPS of $0.52 to $0.53 and full year EPS of $2.60 to $2.64. Street expectations are for EPS of $0.59...

Tesaro Inc. (TSRO) announced after the bell Monday that the FDA has approved Zejula for the maintenance treatment of women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. The stock is now up 8.37 on 373K shares. Tesaro gapped open lower Monday, but traded in a range...

Sportsman's Warehouse Holdings (SPWH) reported fourth quarter EPS of $0.25 after the bell Thursday, down from $0.27 in the previous year. Analysts expected EPS of $0.26. The company expects to report a first quarter loss of $0.08 to $0.06 and a full year profit of $0.60 to $0.68. Street expectations...

GameStop Corp. (GME) reported fourth quarter EPS of $2.38 after the close Thursday, down from $2.40 a year ago. Revenues fell 13.6% to $3.05 billion from $3.53 billion last year. Street expectations were for EPS of $2.29 and revenues of $3.1 billion. The stock is now down 2.76 on just over 1 million...

Micron Technology (MU) reported second quarter EPS of $0.90 after the bell Thursday, up from $0.01 in the prior year period. The consensus estimate was for EPS of $0.85. The stock is now up 2.68 on 10.6 million shares. Micron Technology gapped open higher Thursday and took out the session highs late...

HTG Molecular Diagnostics (HTGM) announced after the bell Wednesday that it has obtained CE marking in the European Union for its HTG EdgeSeq ALKPlus Assay EU. The stock is now up 1.11 on 124K shares. HTG Molecular Diagnostics traded in a narrow range throughout Wednesday's session and closed up by 0.17 at $2.14.

PVH Corp. (PVH) reported fourth quarter EPS of $1.23 after the close Wednesday, down from $1.52 last year. The consensus estimate was for EPS of $1.19. The stock is now up 6.96 on 279K shares. PVH declined until around 1:30PM Wednesday, but recovered some ground in late trade. The stock ended the...

Bellicum Pharmaceuticals Inc. (BLCM) announced after the bell Wednesday that it has commenced an underwritten public offering of 5,000,000 shares of its common stock. The stock is now down 0.67 on 18K shares. Bellicum Pharmaceuticals posted modest gains in early trade Wednesday, but settled into a...

Ultragenyx Pharmaceutical (RARE) announced after the close Wednesday that it Phase 2 study of UX007 in glucose transporter type-1 deficiency syndrome patients with seizures did not meet the primary endpoint. The stock is now down 4.36 on 61K shares. Ultragenyx Pharmaceutical traded in a range for...

Follow RTT